US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Caris Life Sciences, Inc.

20.85

-0.2000-0.95%

Pre-market: 20.80-0.0542-0.26%08:50 EST

Volume:1.32M

Turnover:27.64M

Market Cap:5.88B

PE:-8.63

High:21.39

Open:21.15

Low:20.70

Close:21.05

52wk High:42.50

52wk Low:20.27

Shares:282.15M

Float Shares:91.92M

Volume Ratio:0.73

T/O Rate:1.44%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.4170

EPS(LYR):-10.6561

ROE:--

ROA:-42.48%

PB:12.30

PE(LYR):-1.96

Loading ...

Overview Company News Filings

Earning Preview: Caris Life Sciences, Inc. this quarter’s revenue is expected to increase by 0%, and institutional views are mixed

Caris Life Sciences Initiated at Outperform by Baird

Caris Life Sciences initiated with an Outperform at Baird

CAI Corp Completes Connected Deals, Boosts Controlling Shareholder’s Stake

CAI Corp Updates Market on HK$0.14 Net Asset Value per Share

CAI Corp Wins Strong Shareholder Backing for Equity Deals and 2026 Share Scheme

Caris Life Sciences Inc. to report fourth quarter and full year 2025 financial results

Press Release: AudioCodes Reports Fourth Quarter and Full Year 2025 Results and Declares Semi-Annual Dividend of 20 cents per share

CAI Corp Sets Out Board Line-Up and Committee Roles

CAI Corp Executive Director Chan Cheong Yee to Resign in February 2026

Caris Life Sciences Identifies Key Resistance Mechanisms to Trastuzumab Deruxtecan in Metastatic Breast Cancer

Caris Life Sciences' Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan

THOMSON REUTERS

CAI Corp. to Seek Shareholder Approval for Equity Transfers, New Share Scheme

MT Newswires Live

CAI Corp Calls EGM to Approve Share-Funded Acquisitions From Longling Capital

CAI Corp Reports Unaudited Net Asset Value Per Share of HK$0.14 as of End-2025

Could Caris Life Sciences (CAI)–Everlywell Cancer Test Tie-Up Redefine Its Precision Medicine Positioning?

Simply Wall St.

Caris Life Sciences Showcases Advances in Precision Oncology and Molecular Diagnostics in New Presentation

Caris Life Sciences sees Q4 revenue $281M, consensus $204.31M

Caris Life Sciences Reports Preliminary 116% Revenue Increase for Q4 2025

Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CAI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CAI\",,,,,undefined,":{"symbol":"CAI","market":"US","secType":"STK","nameCN":"Caris Life Sciences, Inc.","latestPrice":20.85,"timestamp":1771534800000,"preClose":21.05,"halted":0,"volume":1322501,"hourTrading":{"tag":"盘前","latestPrice":20.7958,"preClose":20.85,"latestTime":"08:50 EST","volume":1910,"amount":39795.249189999995,"timestamp":1771595411405,"change":-0.0542,"changeRate":-0.0026,"amplitude":0.028297},"delay":0,"changeRate":-0.009501187648456023,"floatShares":91917486,"shares":282146923,"eps":-2.417,"marketStatus":"Pre-Mkt","change":-0.2,"latestTime":"02-20 09:06:45 EST","open":21.15,"high":21.39,"low":20.7,"amount":27644780.62841,"amplitude":0.032779,"askPrice":21.08,"askSize":70,"bidPrice":20.35,"bidSize":470,"shortable":3,"etf":0,"ttmEps":-2.417,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771597800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1750219200000,"exchange":"NASDAQ","adjPreClose":20.85,"preHourTrading":{"tag":"盘前","latestPrice":20.7958,"preClose":20.85,"latestTime":"08:50 EST","volume":1910,"amount":39795.249189999995,"timestamp":1771595411405,"change":-0.0542,"changeRate":-0.0026,"amplitude":0.028297},"postHourTrading":{"tag":"盘后","latestPrice":20.78,"preClose":20.85,"latestTime":"19:51 EST","volume":65885,"amount":1372143.9345,"timestamp":1771548699506,"change":-0.07,"changeRate":-0.003357,"amplitude":0.021583},"volumeRatio":0.7268861375236266,"impliedVol":0.6754,"impliedVolPercentile":0.1916},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CAI\",,,,,undefined,":{"symbol":"CAI","floatShares":91917486,"roa":"-42.48%","roe":"--","lyrEps":-10.656077,"volumeRatio":0.7268861375236266,"shares":282146923,"dividePrice":0,"high":21.39,"amplitude":0.032779,"preClose":21.05,"low":20.7,"week52Low":20.27,"pbRate":"12.30","psRate":"9.06","week52High":42.5,"institutionHeld":0,"latestPrice":20.85,"committee":0.740741,"eps":-2.417,"divideRate":0,"volume":1322501,"delay":0,"ttmEps":-2.417,"open":21.15,"prevYearClose":26.98,"prevWeekClose":20.62,"prevMonthClose":23.16,"prevQuarterClose":26.98,"fiveDayClose":21.5,"twentyDayClose":25.48,"sixtyDayClose":24.03,"earningDate":1772035200000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CAI\",params:#limit:5,,,undefined,":[{"date":"2026-02-26","symbol":"CAI","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":0.01,"defaultRemindTime":1772139600000,"name":null,"time":"Post Market","dateTimestamp":1772082000000,"actualEps":null},{"market":"US","date":"2026-01-12","symbol":"CAI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CAI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.4,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":10,"updateTime":1771390800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CAI","date":"2026-02-19","current":-8.626396,"percent":0.302326,"low":-44.067319,"twenty":-36.001677,"median":9.256062,"eighty":14.80937,"high":30.261317,"avg":-8.921747,"sd":25.767343,"marketCap":5939192729},"quantilePoints":[{"date":"2021-02-26","current":26.958035,"twenty":2.836425,"median":9.146199,"eighty":28.310629,"marketCap":747627184},{"date":"2021-03-05","current":26.011338,"twenty":2.869117,"median":9.298505,"eighty":28.363181,"marketCap":721372425},{"date":"2021-03-12","current":30.043434,"twenty":2.869527,"median":9.384346,"eighty":28.768984,"marketCap":833194555},{"date":"2021-03-19","current":27.675965,"twenty":2.872378,"median":9.531106,"eighty":28.843555,"marketCap":767537524},{"date":"2021-03-26","current":27.57732,"twenty":2.872787,"median":9.633561,"eighty":28.768984,"marketCap":764801815},{"date":"2021-04-01","current":28.064377,"twenty":2.872787,"median":9.758169,"eighty":28.996994,"marketCap":778309381},{"date":"2021-04-09","current":26.942296,"twenty":2.890938,"median":9.896622,"eighty":29.023283,"marketCap":747190684},{"date":"2021-04-16","current":27.743783,"twenty":2.906787,"median":10.156913,"eighty":29.023283,"marketCap":769418325},{"date":"2021-04-23","current":25.337292,"twenty":2.906787,"median":10.264754,"eighty":29.023283,"marketCap":702679122},{"date":"2021-04-30","current":11.501042,"twenty":2.906787,"median":10.72734,"eighty":29.023283,"marketCap":745302045},{"date":"2021-05-07","current":11.559155,"twenty":2.906787,"median":10.865793,"eighty":29.023283,"marketCap":749067926},{"date":"2021-05-14","current":11.10746,"twenty":2.929345,"median":10.946005,"eighty":29.023283,"marketCap":719796762},{"date":"2021-05-21","current":10.930481,"twenty":2.943759,"median":10.999686,"eighty":29.023283,"marketCap":708327943},{"date":"2021-05-28","current":10.737652,"twenty":3.01703,"median":10.999686,"eighty":29.023283,"marketCap":695832066},{"date":"2021-06-04","current":11.012367,"twenty":3.073065,"median":11.038727,"eighty":29.023283,"marketCap":713634411},{"date":"2021-06-11","current":9.998035,"twenty":3.103816,"median":11.0381,"eighty":28.996994,"marketCap":647902674},{"date":"2021-06-18","current":10.079921,"twenty":3.125684,"median":11.0381,"eighty":28.996994,"marketCap":653209142},{"date":"2021-06-25","current":14.763781,"twenty":3.219987,"median":11.059627,"eighty":29.023283,"marketCap":956737305},{"date":"2021-07-02","current":14.763781,"twenty":3.309507,"median":11.111928,"eighty":29.023283,"marketCap":956737305},{"date":"2021-07-09","current":14.74525,"twenty":3.336158,"median":11.126568,"eighty":29.023283,"marketCap":955536452},{"date":"2021-07-16","current":14.891037,"twenty":3.449057,"median":11.236847,"eighty":29.023283,"marketCap":964983876},{"date":"2021-07-23","current":14.936518,"twenty":3.581026,"median":11.28761,"eighty":29.023283,"marketCap":967931186},{"date":"2021-07-30","current":14.944544,"twenty":3.646136,"median":11.326651,"eighty":29.023283,"marketCap":968451299},{"date":"2021-08-06","current":9.360218,"twenty":3.752407,"median":11.370572,"eighty":29.023283,"marketCap":967584443},{"date":"2021-08-13","current":9.363572,"twenty":3.848686,"median":11.370572,"eighty":29.023283,"marketCap":967931186},{"date":"2021-08-20","current":9.38873,"twenty":3.898716,"median":11.370572,"eighty":29.023283,"marketCap":970531753},{"date":"2021-08-27","current":9.375312,"twenty":3.945116,"median":11.370572,"eighty":29.049822,"marketCap":969144784},{"date":"2021-09-03","current":9.390407,"twenty":4.024071,"median":11.370572,"eighty":29.049822,"marketCap":970705124},{"date":"2021-09-10","current":9.365249,"twenty":4.076458,"median":11.370572,"eighty":29.049822,"marketCap":968104557},{"date":"2021-09-17","current":9.368604,"twenty":4.110509,"median":11.370572,"eighty":29.049822,"marketCap":968451299},{"date":"2021-09-24","current":9.368604,"twenty":4.156375,"median":11.370572,"eighty":29.049822,"marketCap":968451299},{"date":"2021-10-01","current":9.376989,"twenty":4.213229,"median":11.370724,"eighty":29.050072,"marketCap":969318155},{"date":"2021-10-07","current":9.380344,"twenty":4.238981,"median":11.370724,"eighty":29.050072,"marketCap":969664897},{"date":"2021-10-15","current":9.378667,"twenty":4.266668,"median":11.380332,"eighty":29.050823,"marketCap":969491526},{"date":"2021-10-22","current":9.378667,"twenty":4.284214,"median":11.383933,"eighty":29.120677,"marketCap":969491526},{"date":"2021-10-29","current":9.382021,"twenty":4.305342,"median":11.383933,"eighty":29.120677,"marketCap":969838269},{"date":"2021-11-05","current":9.383698,"twenty":4.32826,"median":11.383933,"eighty":29.120677,"marketCap":970011640},{"date":"2021-11-09","current":6.915273,"twenty":4.340793,"median":11.383933,"eighty":29.120677,"marketCap":961803774},{"date":"2025-06-20","current":-27.445954,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7736739976},{"date":"2025-06-27","current":-26.374479,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7434701838},{"date":"2025-07-03","current":-26.167427,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7376335954},{"date":"2025-07-11","current":-26.246304,"twenty":9.383698,"median":19.818182,"eighty":28.465108,"marketCap":7398570576},{"date":"2025-07-18","current":-30.845816,"twenty":9.382356,"median":19.818182,"eighty":28.465108,"marketCap":8695126991},{"date":"2025-07-25","current":-29.076014,"twenty":9.380344,"median":19.818182,"eighty":28.465108,"marketCap":8196237652},{"date":"2025-08-01","current":-27.685808,"twenty":9.378667,"median":19.818182,"eighty":28.465108,"marketCap":7804352434},{"date":"2025-08-08","current":-28.188649,"twenty":9.377325,"median":19.778051,"eighty":28.363181,"marketCap":7946098151},{"date":"2025-08-15","current":-37.278729,"twenty":9.37397,"median":15.016779,"eighty":28.059445,"marketCap":10402480346},{"date":"2025-08-22","current":-38.41755,"twenty":9.371958,"median":14.936518,"eighty":27.857377,"marketCap":10720263606},{"date":"2025-08-29","current":-38.528408,"twenty":9.368604,"median":14.909765,"eighty":27.685829,"marketCap":10751198260},{"date":"2025-09-05","current":-36.633734,"twenty":9.365249,"median":14.888362,"eighty":27.527351,"marketCap":10222496907},{"date":"2025-09-12","current":-34.47703,"twenty":9.360553,"median":14.824668,"eighty":27.293717,"marketCap":9620677282},{"date":"2025-09-19","current":-33.690942,"twenty":7.38442,"median":14.763781,"eighty":26.71778,"marketCap":9401322465},{"date":"2025-09-26","current":-29.962061,"twenty":-25.851919,"median":14.718778,"eighty":26.293958,"marketCap":8360793206},{"date":"2025-10-03","current":-29.941905,"twenty":-26.165455,"median":11.559155,"eighty":25.35941,"marketCap":8355168724},{"date":"2025-10-10","current":-31.504003,"twenty":-26.421805,"median":11.424439,"eighty":24.232627,"marketCap":8791066116},{"date":"2025-10-17","current":-32.199389,"twenty":-27.275648,"median":11.239535,"eighty":23.200759,"marketCap":8985110761},{"date":"2025-10-24","current":-31.907126,"twenty":-27.85145,"median":10.925198,"eighty":22.717001,"marketCap":8903555765},{"date":"2025-10-31","current":-31.413301,"twenty":-29.076014,"median":10.711237,"eighty":22.474875,"marketCap":8765755945},{"date":"2025-11-07","current":-37.133331,"twenty":-29.570316,"median":10.518408,"eighty":22.474875,"marketCap":6943635775},{"date":"2025-11-14","current":-36.66558,"twenty":-29.872671,"median":10.079921,"eighty":22.474875,"marketCap":6856170228},{"date":"2025-11-21","current":-36.258185,"twenty":-30.266418,"median":9.392084,"eighty":22.474875,"marketCap":6779990559},{"date":"2025-11-28","current":-38.521493,"twenty":-30.494182,"median":9.38873,"eighty":22.474875,"marketCap":7203210944},{"date":"2025-12-05","current":-42.731244,"twenty":-30.709853,"median":9.383698,"eighty":22.390599,"marketCap":7990400859},{"date":"2025-12-12","current":-40.045453,"twenty":-31.411285,"median":9.382021,"eighty":21.98126,"marketCap":7488179336},{"date":"2025-12-19","current":-42.037163,"twenty":-31.770064,"median":9.380344,"eighty":21.917049,"marketCap":7860613274},{"date":"2025-12-26","current":-42.610535,"twenty":-32.023314,"median":9.378667,"eighty":21.917049,"marketCap":7967829105},{"date":"2026-01-02","current":-40.709356,"twenty":-33.019743,"median":9.376989,"eighty":21.917049,"marketCap":7612323982},{"date":"2026-01-09","current":-42.625623,"twenty":-33.660707,"median":9.375312,"eighty":21.911699,"marketCap":7970650574},{"date":"2026-01-16","current":-40.920598,"twenty":-34.325859,"median":9.371958,"eighty":14.957921,"marketCap":7651824551},{"date":"2026-01-23","current":-38.55167,"twenty":-35.122025,"median":9.368604,"eighty":14.936518,"marketCap":7208853882},{"date":"2026-01-30","current":-38.023565,"twenty":-36.062032,"median":9.366927,"eighty":14.901739,"marketCap":7110102459},{"date":"2026-02-06","current":-32.063522,"twenty":-36.001677,"median":9.365249,"eighty":14.891037,"marketCap":5995622113},{"date":"2026-02-13","current":-31.158199,"twenty":-36.001677,"median":9.358541,"eighty":14.824668,"marketCap":5826333959},{"date":"2026-02-19","current":-31.761748,"twenty":-36.001677,"median":9.256062,"eighty":14.80937,"marketCap":5939192729}],"updateTime":1771596405882},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CAI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1100915787","title":"Earning Preview: Caris Life Sciences, Inc. this quarter’s revenue is expected to increase by 0%, and institutional views are mixed","url":"https://stock-news.laohu8.com/highlight/detail?id=1100915787","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1100915787?lang=en_us&edition=fundamental","pubTime":"2026-02-19 17:41","pubTimestamp":1771494072,"startTime":"0","endTime":"0","summary":"Abstract Caris Life Sciences, Inc. will release its quarterly results on October 26, 2026 Post Market; this preview consolidates company data and market commentary to frame expectations for revenue,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Caris Life Sciences, Inc. this quarter’s revenue is expected to increase by 0%, and institutional views are mixed","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"gpt_icon":0},{"id":"2612455977","title":"Caris Life Sciences Initiated at Outperform by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2612455977","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612455977?lang=en_us&edition=fundamental","pubTime":"2026-02-17 18:30","pubTimestamp":1771324200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CAI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 17, 2026 05:30 ET (10:30 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI"],"gpt_icon":0},{"id":"2612455637","title":"Caris Life Sciences initiated with an Outperform at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2612455637","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612455637?lang=en_us&edition=fundamental","pubTime":"2026-02-17 18:05","pubTimestamp":1771322713,"startTime":"0","endTime":"0","summary":"Baird initiated coverage of Caris Life Sciences (CAI) with an Outperform rating and $26 price target Caris is a commercial-stage precision oncology...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-initiated-with-an-outperform-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-initiated-with-an-outperform-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI"],"gpt_icon":0},{"id":"2611105881","title":"CAI Corp Completes Connected Deals, Boosts Controlling Shareholder’s Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2611105881","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611105881?lang=en_us&edition=fundamental","pubTime":"2026-02-16 13:07","pubTimestamp":1771218462,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) just unveiled an announcement. CAI Corp has completed previously announced discloseable and connected tr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-completes-connected-deals-boosts-controlling-shareholders-stake?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-completes-connected-deals-boosts-controlling-shareholders-stake?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI","BK4139","BK4104"],"gpt_icon":0},{"id":"2611548361","title":"CAI Corp Updates Market on HK$0.14 Net Asset Value per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2611548361","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611548361?lang=en_us&edition=fundamental","pubTime":"2026-02-13 20:16","pubTimestamp":1770984983,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) just unveiled an update. CAI Corp has reported an unaudited net asset value per share of approximately H...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-updates-market-on-hk0-14-net-asset-value-per-share?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-updates-market-on-hk0-14-net-asset-value-per-share?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","BK4139","CAI"],"gpt_icon":0},{"id":"2610643531","title":"CAI Corp Wins Strong Shareholder Backing for Equity Deals and 2026 Share Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2610643531","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610643531?lang=en_us&edition=fundamental","pubTime":"2026-02-10 17:31","pubTimestamp":1770715860,"startTime":"0","endTime":"0","summary":"The latest announcement is out from China New Economy Fund Ltd. ( ($HK:0080) ). CAI Corp shareholders approved all resolutions at an extraordinary ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-wins-strong-shareholder-backing-for-equity-deals-and-2026-share-scheme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-wins-strong-shareholder-backing-for-equity-deals-and-2026-share-scheme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQR","BK4215","BK4104","BK4588","BK4585","CAI","BK4139"],"gpt_icon":0},{"id":"2610653035","title":"Caris Life Sciences Inc. to report fourth quarter and full year 2025 financial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2610653035","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610653035?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:30","pubTimestamp":1770643842,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. The company will host a conference call and live webcast at 3:30 p.m. CT  to discuss the results. The webcast can be accessed at Live Webcast.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via PR Newswire  on February 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL3wVMkh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAI"],"gpt_icon":0},{"id":"2608847309","title":"Press Release: AudioCodes Reports Fourth Quarter and Full Year 2025 Results and Declares Semi-Annual Dividend of 20 cents per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2608847309","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608847309?lang=en_us&edition=fundamental","pubTime":"2026-02-03 15:00","pubTimestamp":1770102000,"startTime":"0","endTime":"0","summary":"-- Quarterly revenues increased by 1.7% year-over-year to $62.6 million;Full. year 2025 revenue increased by 1.4% to $245.6 million.-- Quarterly services revenues increased by 1.0% year-over-year to $34.6. million;Full year 2025 services revenues increased by 0.4% to $130.7. -- Quarterly GAAP net income was $1.9 million, or $0.07 per diluted. -- Full year 2025 GAAP net income was $9.0 million, or $0.31 per. quarter and $29.4 million for the full year 2025.EBITDA for the fourth quarter of 2025 was $4.9 million compared to $5.2 million for the fourth quarter of 2024. EBITDA was $18.3 million in 2025 compared to $21.1 million in 2024.On a Non-GAAP basis, EBITDA for the fourth quarter of 2025 was $6.5 million compared to $8.5 million for the fourth quarter of 2024. EBITDA was $24.8 million in 2025 compared to $31.4 million in 2024.On a Non-GAAP basis, net income was $4.5 million, or $0.16 per diluted share, for the fourth quarter of 2025 compared to $11.6 million, or $0.37 per diluted shar","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4139","BK4587","BK4020","CAI","ARR","BK4585","BK4543","AUDC","BK4110","BK4528","BK4588","BK4104","BK4551"],"gpt_icon":1},{"id":"2608880620","title":"CAI Corp Sets Out Board Line-Up and Committee Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2608880620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608880620?lang=en_us&edition=fundamental","pubTime":"2026-02-02 08:39","pubTimestamp":1769992768,"startTime":"0","endTime":"0","summary":"An announcement from China New Economy Fund Ltd. ( ($HK:0080) ) is now available. CAI Corp has announced the current composition of its board of di...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-sets-out-board-line-up-and-committee-roles?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-sets-out-board-line-up-and-committee-roles?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","CAI","BK4139"],"gpt_icon":0},{"id":"2607013613","title":"CAI Corp Executive Director Chan Cheong Yee to Resign in February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2607013613","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607013613?lang=en_us&edition=fundamental","pubTime":"2026-01-30 17:16","pubTimestamp":1769764570,"startTime":"0","endTime":"0","summary":"An announcement from China New Economy Fund Ltd. ( ($HK:0080) ) is now available. CAI Corp has announced that executive director Chan Cheong Yee wi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-executive-director-chan-cheong-yee-to-resign-in-february-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-executive-director-chan-cheong-yee-to-resign-in-february-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CAI","BK4104"],"gpt_icon":0},{"id":"2606110167","title":"Caris Life Sciences Identifies Key Resistance Mechanisms to Trastuzumab Deruxtecan in Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2606110167","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606110167?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:31","pubTimestamp":1769607086,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. has published a new study in Nature's npj Breast Cancer journal detailing mechanisms of resistance to trastuzumab deruxtecan  in metastatic breast cancer. The study, which analyzed real-world data from 2,799 T-DXd-treated patients, identified ERBB2  and ABCC1 as key transcriptomic predictors of overall survival specific to T-DXd treatment. Higher ERBB2 expression was associated with improved outcomes, while higher ABCC1 expression correlated with poorer outcomes, independent of HER2 category. The research also found that increased ABCC1 expression and enrichment of mutations in ERBB2, NFE2L2, KEAP1, and TOP1 were present in post-treatment samples, suggesting routes to acquired resistance. The results of this study have already been published.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpose","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL8B5W6P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAI"],"gpt_icon":0},{"id":"2606711710","title":"Caris Life Sciences' Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan","url":"https://stock-news.laohu8.com/highlight/detail?id=2606711710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606711710?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:30","pubTimestamp":1769607000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUA93BCSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4104","BK4139","CAI"],"gpt_icon":0},{"id":"2605122164","title":"CAI Corp. to Seek Shareholder Approval for Equity Transfers, New Share Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2605122164","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605122164?lang=en_us&edition=fundamental","pubTime":"2026-01-21 12:06","pubTimestamp":1768968366,"startTime":"0","endTime":"0","summary":"CAI Corp.  will hold an extraordinary general meeting on Feb. 10 to seek shareholder approval for two equity transfer agreements involving share issuances, as well as the adoption of a new share scheme, according to a Tuesday Hong Kong bourse filing.Shares of the firm were down more than 1% in Wednesday morning trade.Under the proposals, shareholders will be asked to approve two equity transfer agreements with Longling Capital.The first transaction involves consideration of about HK$52.3 million, to be settled through the issue of up to 145.2 million new shares at an issue price of not less than HK$0.36 per share.The second transaction involves consideration of about HK$19.3 million, to be settled through the issue of up to 53.6 million new shares, also at a minimum issue price of HK$0.36 per share.Separately, the company is seeking approval to adopt a 2026 share scheme, under which the scheme mandate limit will be set at 5% of the total issued shares, excluding treasury shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4104","BK4585","BK4588","BK4215","00080","BK1511","CAI","BK4139","EQR"],"gpt_icon":0},{"id":"2604188151","title":"CAI Corp Calls EGM to Approve Share-Funded Acquisitions From Longling Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2604188151","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604188151?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:10","pubTimestamp":1768911052,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) has shared an update. CAI Corp has called an extraordinary general meeting for 10 February 2026 in Hong ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-calls-egm-to-approve-share-funded-acquisitions-from-longling-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-calls-egm-to-approve-share-funded-acquisitions-from-longling-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI","BK4139","BK4104"],"gpt_icon":0},{"id":"2603167745","title":"CAI Corp Reports Unaudited Net Asset Value Per Share of HK$0.14 as of End-2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2603167745","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603167745?lang=en_us&edition=fundamental","pubTime":"2026-01-15 16:39","pubTimestamp":1768466342,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) has provided an update. CAI Corp has announced that its unaudited net asset value per share stood at app...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-reports-unaudited-net-asset-value-per-share-of-hk0-14-as-of-end-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-reports-unaudited-net-asset-value-per-share-of-hk0-14-as-of-end-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4104","CAI"],"gpt_icon":0},{"id":"2603660439","title":"Could Caris Life Sciences (CAI)–Everlywell Cancer Test Tie-Up Redefine Its Precision Medicine Positioning?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603660439","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603660439?lang=en_us&edition=fundamental","pubTime":"2026-01-15 16:32","pubTimestamp":1768465922,"startTime":"0","endTime":"0","summary":"In early January 2026, Caris Life Sciences announced a partnership with digital health company Everlywell to launch Caris Detect, a multi-cancer early detection blood test that applies whole genome sequencing and AI to identify molecular signals of cancer in the bloodstream, with commercialization planned through Everlywell’s platform in the first half of 2026.\nThis collaboration highlights how advanced genomic screening and consumer-focused digital health distribution could broaden access...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cai/caris-life-sciences/news/could-caris-life-sciences-caieverlywell-cancer-test-tie-up-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cai/caris-life-sciences/news/could-caris-life-sciences-caieverlywell-cancer-test-tie-up-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","CAI","BK7104","CAI.AU","BK4104"],"gpt_icon":0},{"id":"2603625529","title":"Caris Life Sciences Showcases Advances in Precision Oncology and Molecular Diagnostics in New Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2603625529","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603625529?lang=en_us&edition=fundamental","pubTime":"2026-01-13 05:50","pubTimestamp":1768254640,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. recently presented at the 44th Annual J.P. Morgan Healthcare Conference, highlighting its leadership in precision oncology, molecular diagnostics, and oncology bioinformatics. The company detailed its expanding offerings in early detection, minimal residual disease , and monitoring, as well as its technology-enabled platform supporting more than 6,000 oncologists in the U.S. Caris also reported continued growth in its Precision Oncology Alliance , now comprising 99 member sites—including 46 NCI-designated cancer centers—and providing access to a clinico-genomic dataset of over 740,000 patients. The company supports research, publication, and clinical trial efforts across more than 700 locations, with a network of over 4,000 oncologists. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL8JgyHq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAI"],"gpt_icon":0},{"id":"2602548227","title":"Caris Life Sciences sees Q4 revenue $281M, consensus $204.31M","url":"https://stock-news.laohu8.com/highlight/detail?id=2602548227","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602548227?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:36","pubTimestamp":1768224987,"startTime":"0","endTime":"0","summary":"An increase of approximately 116% from last year. Completed approximately 52,700 clinical therapy selection cases, an increase of approximately 20%...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-sees-q4-revenue-281m-consensus-204-31m-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-sees-q4-revenue-281m-consensus-204-31m-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI"],"gpt_icon":0},{"id":"2602996548","title":"Caris Life Sciences Reports Preliminary 116% Revenue Increase for Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2602996548","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602996548?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:30","pubTimestamp":1768224659,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. announced preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025. The company reported total revenue of approximately $281 million for the fourth quarter of 2025, representing an increase of about 116% compared to the same period in 2024. For the full year, Caris Life Sciences recorded revenue growth of approximately 94%, primarily driven by strong performance in molecular profiling services. These results are subject to change as the company completes its customary year-end close and review procedures. Final audited results will be reported during the company's earnings call in late February 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL3zTHM9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAI","BK4104"],"gpt_icon":0},{"id":"2602548988","title":"Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2602548988","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602548988?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:30","pubTimestamp":1768224602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA2MWKSP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4104","CAI","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":73,"code":"91000000","status":"200"}]}}